A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune disease.
J Autoimmun
; 95: 1-14, 2018 12.
Article
in En
| MEDLINE
| ID: mdl-30446251
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Autoimmune Diseases
/
Recombinant Fusion Proteins
/
Immunoglobulin G
/
Interleukin-2
/
Lymphotoxin-alpha
/
T-Lymphocytes, Regulatory
/
Immunotherapy
Type of study:
Prognostic_studies
Language:
En
Journal:
J Autoimmun
Journal subject:
ALERGIA E IMUNOLOGIA
Year:
2018
Document type:
Article